Status: Recruiting
THE-0504 in Patients With Solid Tumors
Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.
Participants needed: 30
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Thena Biotech S.r.l.Updated: Jun 12, 2026Locations: 1
Eligibility criteria
written informed consent obtained; [+12]
pregnant (as determined by a blood pregnancy test at the screening visit) or lac... [+28]